Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk factors for non-melanoma skin cancer in patients with essential thrombocythemia and polycythemia vera.

European journal of haematology - 1 Mar 2016

Gómez Montse, Guillem Vicent, Pereira Arturo, Ferrer-Marín Francisca, Álvarez-Larrán Alberto, Kerguelen Ana, Estrada Natàlia, Martínez-López Joaquín, Angona Anna, Amat Paula, Navarro Blanca, Besses Carles, Hernández-Boluda Juan-Carlos

Abstract excerpt

OBJECTIVES: Population-based studies have reported an increased incidence of skin cancer in patients with essential thrombocythemia (ET) and polycythemia vera (PV). We have examined the risk factors for non-melanoma skin cancer (NMSC) in patients diagnosed with ET or PV during 1973-2012. METHODS: A case-control study was performed to compare the clinical and treatment-related data of 51 ET/PV patients who had...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child, Preschool
Share to Infant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Odds Ratio

Share to Polycythemia Vera

Share to Population Surveillance

Share to Skin Neoplasms

Share to Thrombocythemia, Essential

Share to Young Adult

Source

Identifiers

PMID: 25996073
DOI: 10.1111/ejh.12588

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk factors for non-melanoma skin cancer in patients with essential thrombocythemia and polycythemia vera.PMID 25996073Read ↗

Associated cancers in parents and offspring of polycythaemia vera and myelofibrosis patients.Semantic proximity Read ↗

Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera.Semantic proximity Read ↗

Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden.Semantic proximity Read ↗

DNMT3A/TET2/ASXL1 mutations are an age-independent thrombotic risk factor in polycythemia vera patients: an observational studySemantic proximity Read ↗

Immune Checkpoint Inhibitors and Car-T Cell Therapy: Thrombotic and Vascular ComplicationsSemantic proximity Read ↗

DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study.Semantic proximity Read ↗

Lethal toxicity of anticancer drugs in Xeroderma pigmentosumSemantic proximity Read ↗

Genetic factors influencing the development of vincristine-induced neurotoxicity.Semantic proximity Read ↗

Treatment of Essential Thrombocythemia with Anagrelide Is Associated with an Increased Risk of Worsened Kidney Function.Semantic proximity Read ↗

The Role of DNA Repair (XPC, XPD, XPF, and XPG) Gene Polymorphisms in the Development of Myeloproliferative Neoplasms.Semantic proximity Read ↗

CYP1AI, glutathione S-transferase gene polymorphisms and risk of Polycythemia vera.Semantic proximity Read ↗

Association of the 609 C/T NAD(P)H: quinone oxidoreductase (NQO1) polymorphism with development of cutaneous malignant melanomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.